SEARCH

SEARCH BY CITATION

References

  • Bates, S., Hughes, H.B., Munro, C.A., Thomas, W.P., MacCallum, D.M., Bertram, G., et al. (2006) Outer chain N-glycans are required for cell wall integrity and virulence of Candida albicans. J Biol Chem 281: 9098.
  • Bose, I., Reese, A.J., Ory, J.J., Janbon, G., and Doering, T.L. (2003) A yeast under cover: the capsule of Cryptococcus neoformans. Eukaryot Cell 2: 655663.
  • Bruno, V.M., and Mitchell, A.P. (2004) Large-scale gene function analysis in Candida albicans. Trends Microbiol 12: 157161.
  • Casadevall, A., and Scharff, M.D. (1991) The mouse antibody response to infection with Cryptococcus neoformans: VH and VL usage in polysaccharide binding antibodies. J Exp Med 174: 151160.
  • Casadevall, A., and Perfect, J.R. (1998) Cryptococcus Neoformans. Washington, DC: American Society for Microbiology Press.
  • Chaka, W., Verheul, A.F.M., Vaishnav, V.V., Cherniak, R., Scharringa, J., Verhoef, J., et al. (1997) Cryptococcus neoformans and cryptococcal glucuronoxylomannan, galactoxylomannan, and mannoprotein induce different levels of tumor necrosis factor alpha in human peripheral blood mononuclear cells. Infect Immun 65: 272278.
  • Chang, Y.C., and Kwon-Chung, K.J. (1994) Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence. Mol Cell Biol 14: 49124919.
  • Chang, Y.C., and Kwon-Chung, K.J. (1998) Isolation of the third capsule-associated gene CAP60, required for virulence in Cryptococcus neoformans. Infect Immun 66: 22302236.
  • Chang, Y.C., and Kwon-Chung, K.J. (1999) Isolation, characterization, and localization of a capsule-associated gene, CAP10, of Cryptococcus neoformans. J Bacteriol 181: 56365643.
  • Chang, Y.C., Penoyer, L.A., and Kwon-Chung, K.J. (1996) The second capsule gene of Cryptococcus neoformans, CAP64, is essential for virulence. Infect Immun 64: 19771983.
  • Chang, Y.C., Stins, M.F., Caffery, M.J., Miller, G.F., Pare, D.R., Dam, T., et al. (2004) Cryptococcal yeast cells invade the central nervous system via transcellular penetration of the blood-brain barrier. Infect Immun 72: 49854995.
  • Charlier, C., Chretien, F., Baudrimont, M., Mordelet, E., Lortholary, O., and Dromer, F. (2005) Capsule structure changes associated with Cryptococcus neoformans crossing of the blood-brain barrier. Am J Pathol 166: 421432.
  • Cormack, B.P., Ghori, N., and Falkow, S. (1999) An adhesin of the yeast pathogen Candida glabrata mediating adherence to human epithelial cells. Science 285: 578582.
  • D'Souza, C.A., Alspaugh, J.H., Yue, C., Harashima, T., Cox, G.M., Perfect, J.R., and Heitman, J. (2001) Cyclic AMP-dependent protein kinase controls virulence of the fungal pathogen Cryptococcus neoformans. Mol Cell Biol 21: 31793191.
  • Dromer, F., Salamero, J., Contrepois, A., Carbon, C., and Yeni, P. (1987) Production, characterization, and antibody specificity of a mouse antibody reactive with Cryptococcus neoformans capsular polysaccharide. Infect Immun 55: 742748.
  • Ellerbroek, P.M., Lefeber, D.J., Van Veghel, R., Scharringa, J., Brouwer, E., Gerwig, G.J., et al. (2004) O-acetylation of cryptococcal capsular glucuronoxylomannan is essential for interference with neutrophil migration. J Immunol 173: 75137520.
  • García-Rivera, J., Chang, Y.C., Kwon-Chung, K.J., and Casadevall, A. (2004) Cryptococcus neoformans CAP59 (or Cap59p) is involved in the extracellular trafficking of capsular glucuronoxylomannan. Eukaryot Cell 3: 385392.
  • Giaever, G., Chu, A.M., Ni, L., Connelly, C., Riles, L., Veronneau, S., et al. (2002) Functional profiling of the Saccharomyces cerevisiae genome. Nature 418: 387391.
  • Holden, H.M., Rayment, I., and Thoden, J.B. (2003) Structure and function of enzymes of the Leloir pathway for galactose metabolism. J Biol Chem 278: 4388543888.
  • Hua, J.H., Meyer, J.D., and Lodge, J.K. (2000) Development of positive markers for the fungal pathogen, Cryptococcus neoformans. Clin Diagn Lab Immunol 7: 125128.
  • Hunt, T.A., Kooi, C., Sokol, P.A., and Valvano, M.A. (2004) Identification of Burkholderia cenocepacia genes required for bacterial survival in vivo. Infect Immun 72: 40104022.
  • Ikeda, R., Nishimura, S., Nishikawa, A., and Shinoda, T. (1996) Production of agglutinating monoclonal antibody against antigen 8 specific for Cryptococcus neoformans serotype D. Clin Diagn Lab Immunol 3: 8992.
  • James, P.G., and Cherniak, R. (1992) Galactoxylomannans of Cryptococcus neoformans. Infect Immun 60: 10841088.
  • Janbon, G. (2004) Cryptococcus neoformans capsule biosynthesis and regulation. FEMS Yeast Res 4/8: 765771.
  • Janbon, G., Himmelreich, U., Moyrand, F., Improvisi, L., and Dromer, F. (2001) Cas1p is a membrane protein necessary for the O-acetylation of the Cryptococcus neoformans capsular polysaccharide. Mol Microbiol 42: 453469.
  • Kozel, T.R., Levitz, S.M., Dromer, F., Gates, M.A., Thorkildson, P., and Janbon, G. (2003) Antigenic and biological characteristics of mutant strains of Cryptococcus neoformans lacking capsular O-acetylation or xylosyl side chains. Infect Immun 71: 28682875.
  • Lee, N., and Janbon, G. (2006) Techniques and strategies for studying virulence factors in Cryptococcus neoformans. In Medical Mycology: Cellular and Molecular Techniques. Kavanagh, K. (ed.). Chichester: Wiley & Sons, pp. 275304.
  • Loftus, B., Fung, E., Roncaglia, P., Rowley, D., Amedeo, P., Bruno, D., et al. (2005) The genome and transcriptome of Cryptococcus neoformans, a basidiomycetous fungal pathogen of humans. Science 307: 13211324.
  • Logan, S.M., Conlan, J.W., Monteiro, M.A., Wakarchuk, W.W., and Altman, E. (2000) Functional genomics of Helicobacter pylori: identification of a beta-1,4 galactosyltransferase and generation of mutants with altered lipopolysaccharide. Mol Microbiol 35: 11561167.
  • McFadden, D.C., De Jesus, M., and Casadevall, A. (2006) The physical properties of the capsular polysaccharides from Cryptococcus neoformans suggest features for capsule construction. J Biol Chem 281: 18681875.
  • Mille, C., Janbon, G., Delplace, F., Ibata-Ombetta, S., Gaillardin, C., Strecker, G., et al. (2004) Inactivation of CaMIT1 inhibits Candida albicans phospholipomannan beta-mannosylation, reduces virulence, and alters cell wall protein beta-mannosylation. J Biol Chem 279: 4795247960.
  • Missall, T.A., Pusateri, M.E., Donlin, M.J., Chambers, K.T., Corbett, J.A., and Lodge, J.K. (2006) Posttranslational, translational, and transcriptional responses to nitric oxide stress in Cryptococcus neoformans: implications for virulence. Eukaryot Cell 5: 518529.
  • Moyrand, F., and Janbon, G. (2004) UGD1 encoding the Cryptococcus neoformans UDP-glucose dehydrogenase is essential for growth at 37°C and for capsule biosynthesis. Eukaryot Cell 3: 16011608.
  • Moyrand, F., Klaproth, B., Himmelreich, U., Dromer, F., and Janbon, G. (2002) Isolation and characterization of capsule structure mutant strains of Cryptococcus neoformans. Mol Microbiol 45: 837849.
  • Moyrand, F., Chang, Y.C., Himmelreich, U., Kwon-Chung, K.J., and Janbon, G. (2004) Cas3p belongs to a seven member family of capsule structure designer proteins. Eukaryot Cell 3: 15131524.
  • Nobile, C.J., and Mitchell, A.P. (2005) Regulation of cell-surface genes and biofilm formation by the C. albicans transcription factor Bcr1p. Curr Biol 15: 11501155.
  • Pericolini, E., Cenci, E., Monari, C., De Jesus, M., Bistoni, F., Casadevall, A., and Vecchiarelli, A. (2006) Cryptococcus neoformans capsular polysaccharide component galactoxylomannan induces apoptosis of human T-cells through activation of caspase-8. Cell Microbiol 8: 267275.
  • Roberts, I.A. (1996) The biochemistry and genetics of capsular polysaccharide production in bacteria. Annu Rev Microbiol 50: 285315.
  • Roberts, G.D., Horstmeier, C.D., Land, G.A., and Foxworth, J.H. (1978) Rapid urea broth test for yeasts. J Clin Microbiol 7: 584588.
  • Sawardeker, J.S., Sloneker, J.H., and Jeanes, A. (1965) Quantitative determination of monosaccharides as their alditol acetates by gas liquid chromatography. Anal Biochem 37: 16021604.
  • Seifert, G.J., Barber, C., Wells, B., Dolan, L., and Roberts, K. (2002) Galactose biosynthesis in Arabidopsis: genetic evidence for substrate channeling from UDP-D-galactose into cell wall polymers. Curr Biol 12: 18401845.
  • Sherman, F. (1992) Getting started with yeast. In Guide to Yeast Genetics and Molecular Biology, Vol. 194.Guthrie, C., and Fink, G.R. (eds). San Diego, CA: Academic Press, pp. 321.
  • Späth, G.F., Lye, L.F., Segawa, H., Sacks, D.L., Turco, S.J., and Beverley, S.M. (2003) Persistence without pathology in phosphoglycan-deficient Leishmania major. Proc Natl Acad Sci USA 301: 12411243.
  • Vaishnav, V.V., Bacon, B.E., O'Neill, M., and Cherniak, R. (1998) Structural characterization of the galactoxylomannan of Cryptococcus neoformans Cap67. Carbohydr Res 306: 315330.
  • Van de Moer, A., Salhi, S.L., Cherniak, R., Pau, B., Garrigues, M.L., and Bastide, J.M. (1990) An anti-Cryptococcus neoformans monoclonal antibody directed against galactoxylomannan. Res Immunol 141: 3342.
  • Vecchiarelli, A. (2000) Immunoregulation by capsular components of Cryptococcus neoformans. Med Mycol 38: 407417.
  • Walton, F.J., Idnurm, A., and Heitman, J. (2005) Novel gene functions required for melanization of the human pathogen Cryptococcus neoformans. Mol Microbiol 57: 13811396.